METHYLERGOMETRINE MALEATE INJECTION

Main information

  • Trade name:
  • METHYLERGOMETRINE MALEATE INJECTION Solution for injection 0,2MG/ML
  • Dosage:
  • 0,2MG/ML
  • Pharmaceutical form:
  • Solution for injection
  • Administration route:
  • Intramuscular/intravenous use
  • Units in package:
  • 10X1ML Ampoule
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • METHYLERGOMETRINE MALEATE INJECTION Solution for injection 0,2MG/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • METHYLERGONOVINE
  • Product summary:
  • METHYLERGOMETRINE MALEATE INJECTION 0,2 MG

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization number:
  • F - specific therapeutic programme
  • Last update:
  • 05-04-2018

28-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Europe - EMA - European Medicines Agency

30-7-2018

Apoquel (Zoetis Belgium S.A.)

Apoquel (Zoetis Belgium S.A.)

Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13

Europe -DG Health and Food Safety